Search Results - "Burge, Matthew"

The Therapeutic Landscape for KRAS -Mutated Colorectal Cancers.

Authors: Tria, Simon Manuel Burge, Matthew E. Whitehall, Vicki L. J.

Source: Cancers. Apr2023, Vol. 15 Issue 8, p2375. 25p.

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Authors: Gan, Hui K. Burge, Matthew Solomon, Benjamin et al.

Source: Journal of Nuclear Medicine. Dec2021, Vol. 62 Issue 12, p1-29. 30p.

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Authors: Hui K. Gan Burge, Matthew Solomon, Benjamin et al.

Source: Journal of Nuclear Medicine. 8/1/2021, Vol. 62 Issue 8, p1-30. 30p.

Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia.

Authors: Price, Timothy Burge, Matthew Chantrill, Lorraine et al.

Source: Asia Pacific Journal of Clinical Oncology. Apr2020 Supplement S1, Vol. 16, p3-12. 10p.

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

Authors: Clarke, Stephen John Burge, Matthew Feeney, Kynan et al.

Source: PLoS ONE. 3/6/2020, Vol. 15 Issue 3, p1-11. 11p.

First‐line therapy for metastatic colorectal cancer: Current perspectives and future directions.

Authors: Burge, Matthew Price, Timothy Karapetis, Christos S.

Source: Asia Pacific Journal of Clinical Oncology. Feb2019 Supplement S1, Vol. 15, p3-14. 12p.

Metastatic colorectal cancer during pregnancy: A tertiary center experience and review of the literature.

Authors: Lee, Shu Fen Burge, Matthew Eastgate, Melissa

Source: Obstetric Medicine (1753-495X). Mar2019, Vol. 12 Issue 1, p38-41. 4p.

Competing reaction pathways from α-halo-α-protioalkyl aryl sulfoxides initiated by organometallic reagents

Authors: Blakemore, Paul R. Burge, Matthew S. Sephton, Mark A.

Source: Tetrahedron Letters: International Organ for the Rapid Publication of Preliminary Communications in Organic Chemistry. Jun2007, Vol. 48 Issue 23, p3999-4002. 4p.

Subjects: Solution (Chemistry), Aromatic amines, Alkylation, Chemical reactions

Nitrenium Ion Azaspirocyclization-Spirodienone Cleavage: A New Synthetic Strategy for the Stereocontrolled Preparation of Highly Substituted Lactams and N-Hydroxy Lactams.

Authors: Wardrop, Duncan J. Burge, Matthew S.

Source: Journal of Organic Chemistry. 12/9/2005, Vol. 70 Issue 25, p10271-10284. 14p. 6 Diagrams, 5 Charts.

Subjects: Quinone, Chemistry, Ions, Lactams, Dimethyl sulfide, Sulfides, Atmospheric dimethyl sulfide

π-Face selective azaspirocyclization of ω-(methoxyphenyl)-N-methoxyalkylamides

Authors: Wardrop, Duncan J. Burge, Matthew S. Zhang, Wenming et al.

Source: Tetrahedron Letters: International Organ for the Rapid Publication of Preliminary Communications in Organic Chemistry. Mar2003, Vol. 44 Issue 12, p2587. 5p.

Subjects: Ring formation (Chemistry), Organic synthesis

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.

Authors: Burge, Matthew E. O'Rourke, Nick Cavallucci, David et al.

Source: HPB (1365-182X). Jul2015, Vol. 17 Issue 7, p624-631. 8p.

Successful treatment of a primary mediastinal germ cell tumour complicated by hemophagocytic syndrome.

Authors: BURGE, Matthew ISLAM, Mohammed F MORRIS, Kirk et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2012, Vol. 8 Issue 4, pe97-e98. 2p.

Establishing high risk factors for recurrence in stage I/II colorectal cancer: a metropolitan perspective.

Authors: Wood, Phoebe C. Zammit, Andrew P. Ferris, Baillie et al.

Source: World Journal of Surgical Oncology. 6/18/2025, Vol. 23 Issue 1, p1-8. 8p.

Retrospective Cohort Study of Treatment Patterns and Outcomes for Patients With Locally Advanced Rectal Cancer Across Three Metropolitan Hospitals in Brisbane.

Authors: Macilwraith, Philip Turner, Cassie Roberts, Kate et al.

Source: Asia Pacific Journal of Clinical Oncology. Jun2026, p1. 8p. 3 Illustrations.

The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study.

Authors: Michael, Michael Toner, Guy C. Ganju, Vinod et al.

Source: British Journal of Clinical Pharmacology. Jun2026, Vol. 92 Issue 6, p1652-1665. 14p.

Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial.

Authors: Courneya, Kerry S. Vardy, Janette L. O'Callaghan, Christopher J. et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jun2016, Vol. 25 Issue 6, p969-977.

Prognostic and predictive clinical, pathological, and molecular biomarkers in metastatic colorectal carcinoma - a review.

Authors: van Haeringen, Benjamin Wyld, David Burge, Matthew

Source: Australian Medical Student Journal. 2019, Vol. 9 Issue 1, p30-35. 6p.

Cancer on the margins: experiences of living with neuroendocrine tumours.

Authors: Plage, Stefanie Gibson, Alexandra Burge, Matthew et al.

Source: Health Sociology Review. Jul2018, Vol. 27 Issue 2, p153-167. 15p.

Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.

Authors: Chapman, Suzannah J McKavanagh, Daniel Burge, Matthew E et al.

Source: Asia Pacific Journal of Clinical Oncology. Oct2017, Vol. 13 Issue 5, pe253-e261. 9p.

Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.

Authors: Yang, Tsai‐Sheng Chen, Hong‐Hwa Bo‐Wen, Lin et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2023, Vol. 19 Issue 6, p672-680. 9p.